Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use SINGULAIR safely and effectively. See full prescribing information for SINGULAIR. SINGULAIR® (montelukast sodium) tablets, chewable tablets, and oral granulesInitial U.S. Approval: 1998
Medication labelWhy this: Advisory · dailymed-prescription
SINGULAIR Registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. Copyright © 1998-2010 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved is indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients 12 months of age and older. SINGULAIR is indicated for prevention of exercise-induced bronchoconstriction (EIB) in patients 15 years of age and older. SINGULAIR is indicated for the relief of symptoms of seasonal allergic rhinitis in patients 2 years of age and older and perennial allergic rhinitis in patients 6 months of age and older.
- generic_name
- montelukast sodium
- product_names
- montelukast sodium
- ndc
- 21695-565, 0006-0275, 21695-565-30, 21695-221, 0006-0117, 21695-221-30
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en